May 28 2024University of Houston
While T-cell immunotherapy has revolutionized cancer treatment, there is still much to learn. Unfortunately, not all patients respond to these therapies, so a better understanding of the properties of engineered T cells is necessary to improve clinical responses. "Our results showed that a subset of T cells, labeled as CD8-fit T cells, are capable of high motility and serial killing, found uniquely in patients with clinical response," reports first author and recent UH graduate Ali Rezvan in Nature Cancer.
Chimeric antigen receptors T cells used for the treatment of B cell malignancies can identify T-cell subsets with superior clinical activity. Using infusion products of patients with large B cell lymphoma, we integrated functional profiling using TIMING with subcellular profiling and scRNA-seq to identify a signature of multifunctional CD8 T cells .
Source: Education Headlines (educationheadlines.net)
B Cell Cancer Treatment Cell Drugs Immune System Immunotherapy Lymphoma RNA RNA Sequencing T-Cell
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: The Athletic UK - 🏆 123. / 51 Read more »
Source: medical_xpress - 🏆 101. / 51 Read more »
Source: TIME - 🏆 93. / 53 Read more »
Source: MENnewsdesk - 🏆 23. / 69 Read more »
Source: itvnews - 🏆 69. / 61 Read more »
Source: Metro Newspaper UK - 🏆 61. / 63 Read more »